Search

Your search keyword '"Moss, Steven J."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Moss, Steven J." Remove constraint Author: "Moss, Steven J."
42 results on '"Moss, Steven J."'

Search Results

1. Market Segmentation and Energy Efficiency Program Design

3. Fluorometabolite biosynthesis in Streptomyces cattleya

4. Recombinant strains for the enhanced production of bioengineered rapalogs

5. Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate

10. Isolation of an aldehyde dehydrogenase involved in the oxidation of fluoroacetaldehyde to fluoroacetate in Streptomyces cattleya

11. On the biosynthetic origin of methoxymalonyl-acyl carrier protein, the substrate for incorporation of 'glycolate' units into ansamitocin and soraphen A

12. Diversity oriented biosynthesis via accelerated evolution of modular gene clusters

13. Biosynthesis of the Angiogenesis Inhibitor Borrelidin by Streptomyces parvulus Tü4055Cluster Analysis and Assignment of Functions

14. Uncovering the origin of Z-configured double bonds in polyketides: intermediate E-double bond formation during borrelidin biosynthesis

15. Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency

16. Identification of asm19 as an acyltransferase attaching the biologically essentials ester side chain of ansamitocins using N-desmethyl-4,5-desepoxymaytansinol, not maytansinol, as its substrate

17. Identification of a set of genes involved in the formation of the substrate for the incorporation of the unusual 'glycolate' chain extension unit in ansamitocin biosynthesis

19. Structure guided design of improved anti-proliferative rapalogs through biosynthetic medicinal chemistry

20. Novel FK506 and FK520 analogues via mutasynthesis: mutasynthon scope and product characteristics

21. Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection

22. Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin Family

23. Total Synthesis of Chloptosin: A Dimeric Cyclohexapeptide

25. Optimizing Natural Products by Biosynthetic Engineering: Discovery of Nonquinone Hsp90 Inhibitors

26. Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain

27. Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues

35. Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects

36. The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum.

37. Silent Retreat.

38. Identification of Asm 19 as an Acyltransferase Attaching the Biologically Essential Ester Side Chain of Ansamitocins Using N-Desmethyl-4-,5-desepoxymaytansinol, Not Maytansinol, as Its Substrate.

39. Identification of a Set Genes Involved in thr Formation of the Substrate for the Incorporation of the Unusual 'Glycolate' Chain Extension Unit in Ansamitocin Biosynthesis.

40. Total synthesis of chloptosin: a dimeric cyclohexapeptide.

41. Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms.

42. Biosynthetic engineering of natural products for lead optimization and development.

Catalog

Books, media, physical & digital resources